Phocas Financial Corp’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.3M Sell
248,762
-13,018
-5% -$296K 0.87% 47
2026
Q1
$5.6M Sell
261,780
-73,771
-22% -$1.54M 0.88% 51
2025
Q4
$7.18M Buy
335,551
+103,328
+44% +$2.12M 0.93% 42
2025
Q3
$3.89M Buy
+232,223
New +$3.48M 0.5% 78

Other funds holding MD

Phocas Financial Corp's MD Position: Q2 2026 in Review

Phocas Financial Corp reduced its Pediatrix Medical (MD) stake by 5% in Q2 2026, selling an estimated $296K and leaving 248,762 shares worth $6.3M. The position accounts for 0.87% of the portfolio, ranked #47.

Phocas Financial Corp first reported a position in MD in Q3 2025 and has held it in 4 quarters since. The position peaked at $7.18M in Q4 2025. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Phocas Financial Corp held 248,762 shares of Pediatrix Medical worth $6.3M as of Q2 2026.
  • Phocas Financial Corp sold 13,018 Pediatrix Medical shares in Q2 2026, an estimated $296K.
  • Pediatrix Medical made up 0.87% of Phocas Financial Corp's portfolio in Q2 2026, its #47 holding.
  • Phocas Financial Corp first reported a position in Pediatrix Medical in Q3 2025 and has held it in 4 quarters since.
  • Phocas Financial Corp's Pediatrix Medical position peaked at $7.18M in Q4 2025.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Phocas Financial Corp's 13F filing for Q2 2026, filed 31 Jul 2026.